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Abstract: ONSET AND EXACERBATION OF OBSESSIVE-COMPULSIVE
DISORDER IN PREGNANCY AND THE POSTPARTUM PERIOD.
Mariel A. Focseneanu, C. Neill Epperson. Department of Psychiatry, Yale University,
School of Medicine, New Haven, CT.
The overarching goal of this study was two-fold; to determine the prevalence of
perinatal onset or worsening of OCD symptoms in women attending a university-based
research program, and to determine whether there is a continuity between perinatal onset
or worsening of OCD and premenstrual exacerbation of such symptoms.
Women ages 18 to 69 years old that were enrolled in the Yale OCD Research
Program between 1990 and 1995 were interviewed by phone or in person regarding
demographics, onset and course of OCD, types of primary OCD symptoms, treatment
history, comorbid diagnoses including substance use/abuse, and the impact of pregnancy
and menstruation on OCD onset and symptoms. Those who had at least one pregnancy
were placed into the Preg group and those who had never been pregnant into the NPreg
group. The Preg group was further subdivided; those who reported onset of OCD during
pregnancy or the puerperium were assigned to the Puerperal Related (PR) group while
those that denied onset of OCD related to pregnancy were assigned to the Non-Puerperal
(NP) group. For our secondary aim addressing premenstrual worsening, those women
who were in the PR group were combined with women with pre-existing OCD that
worsened during pregnancy or the postnatal period.
All data were summarized using descriptive statistics (means, SDs,
frequencies). Continuous measures were compared between groups using a Student's ttest and categorical variables were assessed using the chi-square test. All analyses were
considered statistically significant at P <0 .05 and performed using SAS, version 9.1.

Of the Preg group, 24 (30.8%) fell into the PR subgroup; 11 (14.1%) reported
onset during pregnancy, 1 (1.3%) had onset after a miscarriage, and 12 (15.4%) had onset
during the postpartum period. Out of 132 total pregnancies, 29 (22.0%) involved an
improvement in OCD symptoms, 45 (34.1%) involved an exacerbation of symptoms, and
58 (43.9%) did not change symptom severity in women with pre-existing illness.
Although worsening of symptoms prior to menses was reported by the same proportion
of women in the Preg group as in the NPreg group, women in the PR group and those
with perinatal exacerbation were more likely to report premenstrual worsening of OCD
symptoms compared to all others.
Findings from this study provide additional evidence that pregnancy and
childbirth are frequently associated with the onset of OCD or worsening of symptoms in
those with pre-existing disorder. In addition, there appears to be continuity between
OCD onset and/or exacerbation across the reproductive life cycle, at least with
menstruation and pregnancy. These data can not address the impact of menopause on
OCD symptoms. Our findings are consistent with those from other groups, but all need
to be confirmed in prospective studies.
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I.

Background and Rationale

Pregnancy and the puerperium (postpartum) are stages of life traditionally
associated with emotions such as happiness, joy, and excitement for a new mother and
her family. However, there are accounts of puerperal mental illness since the time of
Hippocrates. Primitive theories of the etiology of these childbirth-related disturbances
involved uterine vapors, toxins, and deposits of milk in the brain. Recent speculations
about the causes of puerperal mental illness highlight the importance of psychodynamic
issues, alterations in the neuroendocrine milieu and psychosocial/interpersonal stressors
both specific and nonspecific to childbearing (1). It is now well known that the
puerperium represents a time of increased vulnerability to psychiatric disorders,
particularly depression, psychosis, and the largely understudied obsessive-compulsive
disorder. OCD in the postpartum period often goes undiagnosed and thus untreated,
resulting in devastating consequences for the patient, her family, and the newborn.

1.a. Phenomenology and Natural History of OCD

Obsessive-compulsive disorder is an anxiety disorder characterized by recurrent,
intrusive thoughts or ideas that are recognized as being senseless, yet give rise to anxiety
and distress. In addition, the individual feels urges to perform excessive rituals to
neutralize or suppress these disturbing feelings. Avoidance of situations related to
obsessional concerns is common and contributes to decline in the individual’s ability to
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function at home, work and/or in the social/familial realm. The specific content of
obsessions and compulsions is highly variable and patient-dependent, but a common
theme concerns uncertainty over responsibility for harm or mistakes. Common themes
for obsessional thoughts include: fears of contamination, aggression or violence,
inappropriate sexual activity, need for symmetry, and concerns about making mistakes.
Compulsive behaviors may involve ritualistic checking, washing, counting, or repeating
routine activities. The onset of OCD is typically gradual, occurring over months to years
(2).
OCD is one of the most common psychiatric disorders in the world, with an
estimated lifetime prevalence rate of 2-3% in the general adult population (3). Unlike
depression, which has a female predominance, OCD affects male and female adults
roughly equally (4, 5). Without effective treatment, the course of the illness is usually
chronic and deteriorating, with symptoms interfering significantly with daily functioning
in multiple aspects of life.

1.b. Phenomenology and Prevalence of OCD During Pregnancy

Many studies in recent years have focused on postpartum depression or
psychoses, but little effort has been devoted to studying OCD in the perinatal context.
Interpretation of findings from early studies is complicated by antiquated diagnostic
methods and/or relatively small sample sizes, in addition to being primarily case series
and retrospective reports. To date, no studies have confirmed subject reports of perinatal
or premenstrual worsening of OCD with prospective ratings. Thus the exact incidence or
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prevalence rates of pregnancy or postpartum onset OCD or exacerbation of OCD are
unknown (6). The wide range of percentages reported in the following studies may be a
result of the differing methods of data collection, lack of uniform diagnostic criteria, and
the innate differences in patient populations.
In 1957, Pollitt found that pregnancy and childbirth were associated with the
onset of obsessive symptoms in 11% of 93 patients with OCD (7). Ingram (1961) noted
in his retrospective review of 89 inpatients with “obsessional states” that for 16.9% of the
group, the onset had occurred in association with pregnancy, making it the most common
precipitating event (8). However, Lo (1967) reported such an association in only 5% of
56 OCD patients (9).
More recently, Buttolph and Holland (1990), using a questionnaire limited by a
33% response rate, reported that OCD began during pregnancy in 15% of 39 women and
during the postpartum period in 21% (10). Neziroglu and colleagues found that
approximately 40% of the 64 women with OCD (professionally diagnosed according to
DSM-IIIR criteria) in their study who had been pregnant experienced initial symptom
onset during one of their pregnancies (11). In a related case series, Sichel et al. (1993)
reported on fifteen non-depressed patients with new-onset OCD beginning early in the
postpartum period. Eight women had no previous psychiatric history, and all the patients
responded well to treatment with a serotonergic reuptake blocker (12). On the other
hand, Williams and Koran (1997) reported that only 13% of women in their series who
had been pregnant associated the onset of their OCD (according to DSM-IV criteria) with
pregnancy (13). Maina et al. (1999) reported the onset of OCD at postpartum in 50% of
women who had been pregnant, but no onsets at pregnancy (14). A more recent study by
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Labad (2005) and colleagues of 46 female OCD patients found that OCD onset occurred
at pregnancy in 2% and at postpartum in 7% of the subjects (15).
In addition to these examples of initial symptom onset occurring during the
perinatal period, available research also yields some evidence of exacerbation of preexisting OCD during this time. In 1987, the first report of a case of OCD exacerbation
during pregnancy was published, describing a 26-year-old woman with a fluctuating
course of the illness who experienced a severe and prolonged decompensation during her
second pregnancy (16). Buttolph and Holland (1990) reported that 69% of the 39 female
OCD patients in their study described a relationship between the onset or an exacerbation
of OCD and some aspect of pregnancy, birth, or care of their children. OCD worsened
during pregnancy in 8% of the women, and during the postpartum period in 15%.
Triggering events included infertility, miscarriage, pregnancy, birth and care of the first
child, and birth and care of subsequent children (10).
In another study, miscarriage was a significant risk factor for the recurrence of
OCD in women with pre-existing illness (17). In Labad’s study, worsening of preexisting OCD was reported by 8% of patients at pregnancy and 50% at postpartum (15).
Overall, however, the data on OCD exacerbation during pregnancy is limited and
somewhat equivocal. For example, in the study described above by Williams and Koran,
69% of the 29 women with pre-existing OCD described no change in symptoms during
pregnancy. 17% described worsening, and 14% described improvement. However,
postpartum exacerbation of OCD symptoms was noted by 29% of the patients (13).
Altshuler et al. noted that exacerbation of pre-existing OCD is common in women after
delivery, even when medication discontinuation is successful during pregnancy (18).
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OCD is a heterogeneous disorder in that it can present with a wide variety of
obsessions and compulsions. Despite this diversity of symptoms, previous studies appear
to show a consistent pattern during the puerperium with regard to content of the
obsessions and compulsions. For example, it appears that contamination obsessions and
washing or cleaning rituals are prevalent during pregnancy, while postpartum OCD tends
to be manifested as ego-dystonic intrusive obsessional thoughts of harming the infant,
accompanied by avoidance behaviors or checking rituals (11, 13, 14, 19, 20). In contrast
to the gradual onset of typical OCD, postpartum OCD appears to be characterized by the
rapid onset of obsessional symptoms after the birth. As an example, in the case series
mentioned above by Sichel’s group, the mean time to onset of OCD symptoms was 2.2
weeks after delivery. These symptoms presented primarily as intrusive obsessional
thoughts of harming their babies. Although no associated compulsive rituals developed,
as would be expected in the course of classical OCD, all the women exhibited some
degree of avoidance behavior toward their infants as a response to these obsessions which
they found to be extremely frightening and disturbing (19). In another case series, the
mean time of onset of OCD symptoms was 3.7 weeks following delivery, with onset as
early as the second postpartum day reported (21).

1.c. Neurobiology - Evidence Linking Serotonin, Gonadal Hormones, and OCD

In the past, research on neuropsychiatric disorders has often attempted to
associate each disorder with either a deficiency or an excess within a single
neurotransmitter system. For example, the serotonin hypothesis of OCD was initially
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developed as a result of the finding that serotonin reuptake inhibitors (SRIs) are the most
effective treatment for OCD. However, further studies gave no definitive evidence that a
dysregulation of serotonin function was the primary or only neurochemical disturbance in
OCD. Moreover, only 40-60% of OCD patients respond to SRI monotherapy, and even
these patients may only have a partial response. Thus it must be acknowledged that SRIs
also act via other neurotransmitter systems, and it is likely that OCD is a result of a
disturbance in several of these neurochemical pathways (22). In a comparison of four
studies of various SRIs in OCD patients via meta-analysis, it appeared that greater
improvement in OCD symptoms was actually associated with less selectivity for
serotonin (23). Both serotonergic and dopaminergic systems appear to have a modulating
effect on elements of the basal ganglia circuit that are implicated in OCD, suggesting that
certain cases of OCD (for example, with tics) may respond best to an SRI-neuroleptic
combination (24, 25). Reviewers have also hypothesized that a relative excess of basal
ganglia dopaminergic activity underlies compulsive behaviors (26).
A limited number of imaging studies investigating anatomic brain regions
involved in OCD have been published to date. Although the studies are small and have
varied results, there is some convergence of the data indicating involvement of the
orbitofrontal cortex, the caudate, and the anterior cingulate cortex (27, 28). As further
evidence of involvement of the caudate nucleus, a number of disorders associated with
abnormalities in the caudate including Tourette’s syndrome, Sydenham’s chorea,
Parkinson’s disease, and Huntington’s disease, are frequently accompanied by obsessive
compulsive behaviors (24).
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Since pregnancy and/or childbirth appear to exacerbate or contribute to the onset
of OCD in a sizable portion of women, investigators have theorized that pregnancyspecific psychosocial stresses, parenting responsibilities, and/or changes in the
neuroendocrine milieu are the most likely contributors to this phenomenon. During
pregnancy, there is a profound increase in gonadal steroid (estrogen and progesterone)
levels over 9 months of gestation, only to be followed by a precipitous drop in both
estradiol and progesterone to hypogonadal levels within 48 hours (29). It has been
hypothesized that the extreme fluctuations in these hormones may have an adverse
impact on serotonergic function, producing the notably acute onset of symptoms early in
the postpartum period (12). Few studies have actually tested this hypothesis, but results
from studies in postpartum rats indicate that serotonin receptor changes in the limbic area
are negatively correlated with progesterone levels (30). While between estradiol,
progesterone, and its neurosteroid derivative allopregnanolone (ALLO), multiple
neurotransmitter systems are modulated, the relationship between these steroids and
serotonin have seemed most relevant in the context of OCD in the perinatal period.
The effects of gonadal steroids on serotonin are complex and region specific, but
it is clear that serotonergic neurotransmission (i.e., synthesis, metabolism, uptake, and
receptor sites) is at least partially modulated by changes in estrogen and progesterone
(31-33). Estrogens were found to exert a biphasic effect on the density of serotonin
receptors in the female rat brain: an acute reduction in serotonin receptor density
throughout the brain is followed 48 to 72 hours later by a selective increase in those brain
regions known to contain estrogen receptors--hypothalamus, preoptic area, and amygdala
(34). Iancu et al. presented the case of a woman who developed OCD during a pregnancy
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and recovered completely after giving birth, suggesting a strong biological influence on
the development of the illness; after the hormonal changes abated, the symptoms
disappeared as well (20). It should be noted, however, that this case differs from most
reports of OCD onset during pregnancy, in which the symptoms continued or recurred
after birth.
As further evidence for a temporal relationship between manipulation of gonadal
hormones and a change in OCD symptoms, there have been several case reports
documenting the onset or exacerbation of OCD associated with administration of oral
contraceptives, which alter the individual’s neuroendocrine milieu. In two of these cases,
discontinuation of the exogenous hormones led to clinical improvement (35, 36).
Although all studies have been based on retrospective reports, it appears that a
sizable proportion of women with OCD experience an exacerbation of their primary
symptoms during the premenstruum, thus lending further evidence that ovarian hormones
may contribute to the pathogenesis of OCD in such cases, if not in general (4, 37). In the
Williams and Koran study previously discussed, 42% of the women surveyed reported
regular premenstrual worsening of their OCD (13). Similarly, the Labad study found that
OCD onset occurred in the same year as menarche in 22% of their subjects, and
worsening of preexisting OCD during the premenstruum was reported by 20%. In
addition, the number of premenstrual mood symptoms (including anxiety, irritability,
mood lability, and depressed mood) was associated with both premenstrual worsening of
primary OCD symptoms, and onset or worsening of OCD during the puerperium.
Patients with an onset or exacerbation of OCD during the puerperium also more
frequently reported premenstrual worsening of symptoms and a previous history of major
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depressive disorder, including postpartum depression (15). Premenstrual dysphoria and
high rates of postpartum depression have also been described in female OCD patients in
general (12, 13). Likewise, women with a history of premenstrual syndrome are at higher
risk for postpartum depression and psychosis (38). To link all of these observations, it
has been proposed that a common dysregulation of serotonergic neurotransmission,
which can be accentuated by ovarian steroid fluctuations, may be involved in the
pathophysiology of OCD, postpartum depression, and premenstrual syndrome (24, 39).

1.d. Evidence For Oxytocin Involvement in the Pathogenesis of OCD

While serotonin was the initial and has been the primary neurotransmitter
investigated in the pathophysiology of OCD, poor treatment response to SRIs in up to
40% of OCD patients has made it critical to shift focus to other possible contributors.
Most recently, the hormone oxytocin (40) and neurotransmitters dopamine (41) and
glutamate (42) have been of considerable interest. Given the role of oxytocin in
parturition and lactation, this overview will be limited to discussion of studies examining
oxytocin’s role in OCD. Oxytocin is a nonapeptide synthesized primarily in the
paraventricular and supraoptic nuclei of the hypothalamus, which project to the posterior
pituitary gland (43). Pituitary release of oxytocin into the bloodstream increases in late
pregnancy and the postpartum period, where it stimulates uterine contractions and milk
ejection. Notably, oxytocin has also been implicated as a centrally active neuropeptide
responsible for stimulating sexual, maternal, grooming, and affiliative behaviors in
animals (44-46). Interestingly, it is through the initiation of these “normal” behaviors
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that oxytocin has been purported to play a role in the pathogenesis of OCD. It has been
suggested that the increase in autogrooming observed with oxytocin administration in
rodents (47), for example, may be similar to the repetitive hand washing and cleaning
present in many patients with OCD (40). It is equally conceivable that obsessions
regarding the infant’s safety and compulsions such as checking are pathological
correlates of normal maternal behavior; most new mothers are understandably vigilant
about their baby’s health and welfare.
These central effects may be mediated by projections of oxytocinergic neurons to
extrahypothalamic brain areas, including regions of the brainstem and forebrain (48). For
example, it has been shown that oxytocin fibers from the paraventricular nucleus project
to structures of the limbic system (49), one of the prime candidates for a possible
anatomic site of dysfunction in OCD (22). To further support the association between
oxytocin and OCD, in a 1994 study, Leckman et al. found correlations between
cerebrospinal fluid oxytocin levels and OCD severity among untreated patients (50).
Interestingly, ovarian steroids (namely estrogen) influence both neurosecretory
and intracerebrally projecting oxytocinergic neurons. The concentration of oxytocin and
its receptor in the CNS are responsive to circulating steroid levels (51). For example,
estrogen treatment stimulates the release of oxytocin into the peripheral circulation (52)
and induces oxytocin binding sites in the brain (53). It is unknown how estrogen
mediates these changes, although apparently a subpopulation of oxytocinergic neurons
have binding sites for estradiol (54). In addition, in examination of female rats
undergoing puberty and ovariectomy, Miller et al. showed that ovarian steroids modulate
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neuronal oxytocin mRNA; they observed a significant increase in oxytocin mRNA
concomitant with puberty and reversible with ovariectomy (48).
Thus the brain, in addition to mammary and uterine tissue, appears to be a target
organ for oxytocin in the postpartum period. As further support of this hypothesis, Insel
demonstrated an increase in oxytocin binding in the bed nucleus of stria terminalis
(BNST) of rats during the postpartum period (55). Oxytocin is elevated in the third
trimester of pregnancy and early postpartum period, which coincides with the time that
many women report onset of obsessive-compulsive symptoms. Vaginocervical
stimulation, which occurs with a miscarriage or abortion, has also been shown to increase
oxytocin levels (56), which gives a plausible explanation for the occurrence of these
symptoms after a fetal loss.
However, in contrast to Leckman’s finding of increased CSF oxytocin levels in
patients with OCD, two other studies reported no correlation between OCD symptoms
and CSF oxytocin levels (57, 58). In addition, several investigators attempting to treat
OCD with intranasal oxytocin have reported inconsistent results (59, 60). Most recently,
Epperson et al. found that intranasal oxytocin, even at 3 and 6 times the dosages
previously tested, had no effect on obsessive-compulsive symptoms (61). Given the
difficulty in getting peripherally administered oxytocin across the blood-brain barrier and
into the CNS, it is difficult to conclude that a negative finding indicates no association
between oxytocin and OCD; thus methods must be developed to investigate central
oxytocin function in this disorder.
Still, there are problems with assuming a purely biological (neurohormonal)
etiology of pregnancy related OCD. Importantly, there is no direct evidence that
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hormonal “imbalances” play a causal role. Gonadal hormone influences on CNS
serotonin function vary with length of exposure, dose, and species. In general, the
precise neurobiological mechanisms of OCD remain unclear, and research in this area is
still preliminary. Moreover, biological theories alone do not account for the evident
specificity in symptom presentation among women with puerperial onset OCD.
Abramowitz et al. (2001) also reported an interesting finding of an onset or exacerbation
in OCD symptoms among new fathers, which is inconsistent with a purely biological
model and suggests that the transition to parenthood may entail other factors which
unmask the vulnerability to OCD in these individuals (62).

1.e. Genetic Predisposition to Illness

Although many women with postpartum psychiatric illness have no prior
psychiatric history, there is often a strong family history of affective disorders,
particularly depression and postpartum depression (38). Since the dramatic hormonal
changes described above occur as part of the reproductive cycle in all women, it seems
that the development and exacerbation of mood disorders and OCD at these vulnerable
periods requires more than just fluctuating hormone levels, but also a genetic
predisposition. These currently unidentified genetic “defects” probably relate to subtle
alterations in the number and function of certain receptors and enzymes, as well as minor
structural and anatomical differences in the CNS (39).
There appears to be a definite familial concentration of OCD (63-65).
Interestingly, a study by Lochner, et al. (2004) of a relatively genetically homogenous
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population of subjects revealed that a sexually dimorphic pattern of genetic susceptibility
to OCD may be present (37). These findings were consistent with several earlier studies
of genetics in OCD (63, 66, 67).
Comorbidity data and family genetic studies indicate that 10-20% of OCD cases
probably have a biological relationship to Tourette’s syndrome (TS). Evidence indicates
that OCD and TS may be transmitted together as an autosomal dominant trait with mixed
expressivity, influenced in part by gender – for example, a woman carrying the diathesis
will likely express it as OCD and not TS (24). Clearly, future research focusing on the
role of pregnancy and childbirth in triggering the onset of OCD would benefit from the
inclusion of relevant genetic factors.

1.f. Social Factors Which May Contribute to OCD During Pregnancy

Several studies have reported an earlier onset of obsessive-compulsive disorder
more commonly in men (age 5-15 yrs.), with a later onset (age 23-35 yrs.) more common
in women (68, 69). This may be evidence of gender-divergent etiological factors in
OCD, including certain “triggering” life events for women during this time period,
namely the birth of a child. To further support the concept that the incidence of OCD in
women is highest during childbearing years, it has been reported that the age of onset of
OCD in women has a bimodal distribution, with peak incidences occurring at 13-16 and
22-32 years of age (11). In an investigation of the occurrence of stressful or potentially
triggering events in the recent history of patients with OCD, Maina et al. (1999)
discovered that OCD female individuals were more likely than normal female subjects to
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report exposure to peripartum events. This was the only significant difference found
between OCD and control subjects in terms of number and type of life events. In
addition, it was observed that postpartum OCD was much more frequent in primiparae
(75%), that it frequently follows a pre- and post-term pregnancy (62.5%) and that it is
often associated with delivery by caesarean section (62.5%) (14). Although there was no
control group for comparison, these observations suggest that certain situations
associated with increased stress to the mother (i.e., first child, obstetric complications)
may increase the risk for development of postpartum OCD.
In new mothers with pre-existing OCD or who are otherwise vulnerable (i.e.,
genetic or characterlogic predisposition), the responsibility of looking after a helpless,
totally dependent infant combined with other environmental and family changes after the
birth may be a source of significant psychological stress causing exacerbation or new
onset of the disorder (13). Situations such as being a single mother, an unplanned
pregnancy, and having a poor relationship with one’s own mother may be additional risk
factors (70). In his study, Lo reported that 30% of his postpartum OCD patients
exhibited a fluctuating disease course with exacerbations corresponding to environmental
stress (9).
Interestingly, it appears that pregnancy and the postpartum are also vulnerable
periods for the development of OCD in expecting fathers. Abramowitz et al. described
four males who presented with rapid-onset OCD symptoms associated with their spouse’s
pregnancy or the birth of their child. All the fathers reported unwanted obsessional
thoughts of harming their newborn or unborn child, similar in character to those reported
consistently by pregnant or postpartum women (62). Clearly, this phenomenon further
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highlights the need to look beyond purely biological models to explain puerperial OCD,
and perhaps OCD in general.

1.g. Psychology – primary parental preoccupations and other adaptive behaviors

From an evolutionary perspective on psychopathology, it has been proposed that
highly conserved maternal behavior, while adaptive and crucial for reproductive success,
also leaves women vulnerable to certain forms of mental illness, notably OCD (71).
Maternal behavior includes creating a safe environment for the infant, cleaning, checking,
and nursing, all of which normally become intense parental preoccupations during
pregnancy and the postpartum period. For both parents, the perinatal period often
involves an altered mental state characterized by excitement and heightened sensitivity to
environmental and emotive cues; it has been described as “almost an illness” that a parent
must experience and recover from in order to create and sustain an environment that can
meet the needs of the newborn (72, 73). The infant becomes an increasingly exclusive
focus of thought and action. The intrusive worries that develop concerning parental
adequacy and the infant’s safety, as well as the resultant harm avoidant behavior or
compulsions, resemble thoughts and behaviors encountered in OCD. Thus, it logically
follows that some forms of OCD (i.e., perinatal) may be the result of an inappropriate
activation or lack of down-regulation of the neural circuits normally active during the
initial phases of parental behavior (74).
While it is difficult to imagine the presence of aggressive thoughts toward the
infant as being evolutionarily adaptive, these thoughts appear to be highly correlated with
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checking compulsions, especially in women with postpartum onset major depression
(75); checking may be viewed as maternal vigilance about the infant, and thus potentially
adaptive maternal behavior. In her study of obsessions and compulsions in women with
major depression (postpartum onset vs. non-postpartum onset), Wisner (1999) found that
women with postpartum onset depression experienced a higher frequency of these
aggressive obsessional thoughts (mostly involving harming the infant) than women with
non-postpartum onset (75). Moreover, Jennings et al. found the prevalence of “passing”
aggressive thoughts among postpartum women without depression to be 6.5%, suggesting
that unwanted thoughts concerning harm to the newborn occur fairly frequently even
among healthy women (1 in every 15 childbearing females) (76).
A cognitive-behavioral model has also been proposed as an explanation for
pregnancy or postpartum onset OCD. According to this theory, certain individuals have a
tendency to think and behave in a certain pathological way as a result of prior
experiences. In the case of OCD, vulnerable individuals misappraise common and
benign intrusive, ego-dystonic thoughts as threatening, leading to increased
preoccupation with the thoughts and attempts to neutralize them via compulsive rituals or
avoidance behaviors (77, 78). Essentially, the thought is interpreted as equivalent to the
action (i.e., thinking about violent behavior is the same as committing a violent act). In
this explanation, pregnancy and the postpartum period would be considered especially
vulnerable times for the development of obsessional problems in anyone sharing
responsibility for the infant; the more responsible one feels in a given situation, the worse
it will seem to have violent or negative thoughts (62). In support of this model, it would
account for the development of OCD symptoms in both genders, as well as the success of
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cognitive behavioral therapy as a treatment strategy. However, it cannot be assumed that
these irrational beliefs are the cause of OCD, as empirical studies have primarily been
correlational. In addition, it is difficult to completely ignore the neurobiological
evidence, including the success of SSRIs as a treatment strategy.
One possibility that has been proposed to explain the observed exacerbation of
OCD during pregnancy and the postpartum period involves an overwhelming of one’s
psychological coping mechanisms during these times. Stern and Cobb (1978) reported
that the most common underlying theme in OCD is fear of harming oneself or others
(79). While it may be possible for someone with these obsessions to cope with them by
physically avoiding other people or harmful objects/situations, the physical unity a
pregnant woman has with the fetus may overwhelm her avoidance strategies and lead to
an acute decompensation (16).

1.h. Relationship of OCD with postpartum depression and other co-morbidities

In the nongravid population, major depressive disorder is the most common
comorbid diagnosis in patients with OCD, with lifetime prevalence rates varying from
35-80% (80-82). A similar relationship seems to exist between postpartum OCD and
depression. It is unknown, however, whether OCD symptoms represent a cause or effect
of postpartum depression. It is also possible that OCD and depression could
simultaneously occur as a result of an independent variable, such as neurobiological
changes or increased social/psychological stress in the postpartum period. Whatever the
nature of the relationship, it is clear that the presence of obsessional thoughts regarding
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harming the infant is common among women with postpartum depression – up to 41% of
mothers with depression may have thoughts of harming their infants (76). In addition,
the group of women with pre-existing OCD studied by Williams and Koran experienced
postpartum depression at a rate of 37%, in comparison with the estimated annual
prevalence of postpartum depression of 10%-13% in the general population (13). In
another study, 9 out of 15 women who presented with new onset OCD in the postpartum
period developed a secondary major depression about 2-3 weeks after onset of the
primary obsessive illness (19).
Although these prior studies called the recurrent, ego-dystonic thoughts of
infanticide an obsession consistent with postpartum OCD, the accuracy of this
classification is unclear given the number of women who developed depression, in
addition to the lack of compulsions or other obsessions more typical of OCD. Isolated
obsessions of infanticide occurring in late pregnancy and the postpartum period have also
been reported in the literature as a central psychopathologic feature of women diagnosed
with schizophrenia and depression as well as OCD (83). Future studies are needed to
determine whether intrusive thoughts of infanticide alone represent true OCD, depressive
ruminations, or some other disorder all together.
OCD patients may also have a high lifetime prevalence of panic disorder as well
as other anxiety disorders (84). In Sichel’s case series described above, seven of the
patients had a history of panic disorder, suggesting a similar relationship between
pregnancy-related OCD and other anxiety disorders, and a potential heightened
vulnerability in patients with these illnesses to onset of OCD in the puerperium (19).
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II.

Hypothesis and Study Aims

The primary goal of this study was to examine the impact of pregnancy, childbirth
and menstruation on the onset and/or exacerbation of OCD according to DSM-IIIR
criteria in women attending a university-based OCD Clinic between 1990 and 1995. In
addition, we sought to examine the relationship between reports of menstrual cycle
exacerbation in OCD symptoms and onset or exacerbation of OCD during pregnancy and
the puerperium. We hypothesized that:
1. Within female OCD, there is a subset of patients whose symptoms are
caused or exacerbated by fluctuations in female sex hormones that take
place in the menstrual cycle and in the course of pregnancy and
delivery. Thus women with OCD who reported perinatal onset or exacerbation of their
symptoms would be more likely to experience premenstrual exacerbation of their OCD
symptoms than those women with OCD who have experienced at least one previous
pregnancy but deny perinatal onset or exacerbation of their disorder.
2. Compared with women with a history of pregnancy but no OCD
exacerbations, the hormonally sensitive subgroup will:
(a) Report specific OCD symptoms that correspond with oxytocin-related rodent
postpartum behavior, or that are related to typical human postpartum behavior, including
contamination concerns, checking and cleaning, and aggressive obsessions (related to
harming the infant), which have been frequently reported in the literature.
(b) Report a more acute onset of symptoms, (versus a gradual onset, which is
more typically seen in OCD) corresponding to the rapid changes in hormonal levels.
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(c) Report high rates of co-morbid affective disorders, as well as a strong family
history of OCD and/or postpartum affective disorder. This is based on the existing
literature regarding the significant influence of gonadal hormones on affective disorders,
the relationship of these disorders with OCD, and contributing genetic factors.
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III.

Method

IIIa. Subjects and Recruitment

The data for this study were drawn from the medical records and verbal reports
of individuals referred to the Yale OCD Clinic on the Clinical Neuroscience Research
Unit at Connecticut Mental Health Center in New Haven, CT between 1990 and 1995.
While men enrolled in the Clinic were also interviewed, this project focused on data
obtained from women between age 18 and 69 years who met DSM-IIIR criteria for OCD
according to a Structured Clinical Interview for Diagnosis (85) and had no lifetime
history of an Axis I psychotic disorder or substance dependence disorder within the
previous year. All participants were fluent in English. According to consenting
procedures of the day, women who were already discharged from the OCD Clinic were
sent a letter notifying them that a staff member would be contacting them to conduct an
interview of approximately 30 minutes duration. Women were informed that the purpose
of the interview was to obtain information about the onset and type of OCD symptoms
they experience and how various treatments, substance use, and/or life events may have
impacted their symptoms. Those who wished not to participate could indicate so by
return mail or by phone. If such a request was not received, individuals were contacted
by phone to conduct the interview. Individuals who were actively enrolled in the OCD
Clinic were interviewed when they presented for a scheduled appointment. None of the
active subjects refused to complete the interview.
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For the purposes of this study, women were placed into one of two groups; Ever
Pregnant (Preg) and Never Pregnant (NPreg) by virtue of self-report of their obstetrical
history. Those women who were in the Preg group were further subdivided according to
the following parameters: those who reported onset of OCD during pregnancy or the
puerperium were assigned to the Puerperal Related (PR) group while those that denied
onset of OCD related to pregnancy were assigned to the Non-Puerperal (NP) group.

IIIb. Database and Assessments

During the course of their treatment in the Yale OCD Clinic, patients were
administered a number of clinical interviews including OCD severity ratings and
depression inventories via the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and
the Yale Depression Inventory (YDI), respectively (86). This information was obtained
from each participants Clinic record. The primary goal of the interview, from which data
for this study was extracted, was to develop a complete database of all the patients (both
male and female) who had been or were enrolled in the OCD Clinic. The database
includes information regarding the following areas:
a.

Demographic data: age, sex, marital status (single, married,

divorced, widowed), race, level of education, and occupation.
b.

Clinical features of OCD: age at onset of minor and major

obsessive-compulsive symptoms and age of onset of the major syndrome.
Patients were asked to characterize their obsessions and compulsions from a list
of target symptoms, as well as describe the onset (acute vs. gradual) and course of
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the disease over their lifetime (episodic vs. chronic). In order to investigate the
relationship of their OCD symptoms to reproductive events (in women only),
questions were asked regarding changes in symptoms prior to menses, during
pregnancy, and in the postpartum period.
c.

Other variables: history of substance use, medical history, prior

psychiatric history (including co-morbid psychiatric illness), family history, and
physical or psychological trauma.

IIIc. Statistical analysis

All data were summarized using descriptive statistics (means, SDs,
frequencies). Continuous measures were compared between groups using a Student's ttest and categorical variables were assessed using the chi-square test. All analyses were
considered statistically significant at p < .05 and performed using SAS, version 9.1.

IV.

Results

IVa. Subjects - Pregnant versus Never Pregnant Group Comparisons
Of 140 potential subjects, sufficient data on OCD symptoms in relation to
pregnancy was obtained in 126 women. Since this was the primary focus of our study,
data from the remaining 14 subjects were not included in any analyses. Seventy-eight
women reported having had at least one pregnancy (Preg Group), while 48 women
reported never having been pregnant (NPreg Group).
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Descriptive information for the Preg and NPreg groups is presented in Table 1.
Mean age ± SD at presentation to the Yale OCD Clinic was significantly younger in the
NPreg Group (32.6 ± 13 years) than the Preg Group (40.8 ± 10.8 years) (t=3.82, df=123,
p<0.0002). However, there was no significant difference in age at onset of OCD in the
Preg Group (26 ± 9 years) compared to the NPreg Group (23.8 ± 10.6 years) (t=1.22,
df=120, p=0.70). The Preg group is comprised of 92.0% Caucasian women, 6.7%
Hispanic women, and 1.3% other, while the NPreg group is comprised of 98% Caucasian
and 2% Hispanic women. Compared to women in the NPreg Group, women in the Preg
Group were more likely to be married (X2= 40.5, df =2, p<0.0001) and less educated
(X2=6.4, df=2, p=0.04). Finally, there were no significant differences regarding
comorbid diagnoses or family psychiatric history (including only professionally
diagnosed illness). The majority of women in both groups reported a personal and family
history of depression, substance abuse, and/or other anxiety disorder. Of the women who
reported having co-morbid psychiatric diagnoses, the majority (in all groups) said that
OCD presented first. A minority of subjects reported onset of depression or
trichotillomania before OCD, and one subject who reported OCD onset related to
pregnancy presented with new onset OCD and postpartum depression simultaneously.

Pregnancy Related Onset versus Onset Unrelated to Pregnancy Subgroup
Comparisons
Of the Preg group, 24 (30.8%) fell into the PR subgroup by virtue of having
reported the onset of OCD to be related to either pregnancy, fetal loss, or the postpartum
period. Eleven of the Preg group (14.1%) reported onset during pregnancy, 1 (1.3%) had
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onset after a miscarriage, and 12 (15.4%) had onset during the postpartum period. Thus,
roughly half of the PR subgroup experienced onset during pregnancy while the other half
experienced onset during the puerperium. Table 2 provides descriptive information for
the PR and NP subgroups. Mean age ± SD on admission for the PR (39.3 ± 8.2 years)
and NP (41.5 ±11.8) groups was similar, as was age at onset of OCD (PR subgroup 27 ±
7.1; NP subgroup 25.6 ± 9.8). There were no significant differences in any between
subgroup comparisons with the exception that more women in the NP (22.2%) than in the
PR subgroup (4.2%) carried a comorbid diagnosis which fell into our category of “other”
(X2=3.9, df=1, p=0.05). This category included diagnoses such as trichotillomania,
eating disorders, and Tourette’s syndrome. In addition, women in the NP subgroup
(22.2%) were more likely to report a family history of substance abuse than women in the
PR subgroup (4.2%) (X2=3.9, df=1, p=0.05). While Yale Brown Obsessive Compulsive
Scale (YBOCS) Scores obtained on admission to the OCD Clinic were available on
roughly half of the women in each subgroup, there was a trend for women in the PR (29.5
± 7.0) to have higher YBOCS Scores than women in the NP subgroup (25.7 ± 4.9)
(t=1.93, df=35, p=0.06). YBOCS Scores in this range are consistent with moderate to
severe illness. This is reflected in the baseline global assessment of function (GAF)
scores which were lower in the PR subgroup (51.6 ± 7.1) but not significantly different
from that in the NP (56.3 ± 14.0).

IVb. Course and Characteristics of OCD:
Preg and NPreg Group Comparisons
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As mentioned, there was no significant difference found between the Preg and
NPreg groups in the age of onset of OCD, and the vast majority (greater than 95%)
described their course of illness as chronic rather than episodic. A greater proportion of
women who had been pregnant reported acute onset of symptoms (47.8%), but this did
not differ statistically from women who had never been pregnant (31.4%) (X2=2.56,
df=1, p=0.11).
The frequency of specific types of OCD symptoms in the Preg and NPreg groups
is depicted in Table 6. Significant differences in specific types of symptoms were present
only for religious/scrupulosity obsessions (X2=6.01, df=1, p=0.01), ordering/arranging
compulsions (X2=5.51, df=1, p=0.02), and miscellaneous compulsions (X2=6.633, df=1,
p=0.01). There was also a trend for women in the NPreg Group to report having sexual
obsessions (X2=3.25, df=1, p=0.07) and a greater number of symptoms overall (t=1.8,
df=123, p=0.07). Approximately 21% of women with OCD who had been pregnant
experienced obsessions regarding harming their infant.

PR and NP Subgroup Comparisons
Women with pregnancy-related onset of OCD had a similar number of
pregnancies as those with OCD onset unrelated to pregnancy, although onset of OCD
with pregnancy was most likely to occur during or after the first pregnancy (Table 4). As
was expected with any index event serving as a trigger for symptom onset, 62% of
women in the PR subgroup reported acute onset of OCD symptoms compared to 42% in
the NP subgroup. However, this difference was not statistically significant (X2=2.4,
df=1, p=0.12). Of the 12 women who reported postpartum onset of OCD, 10 answered
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the question of how long after delivery their symptoms began. Seven out of the 10
reported that the onset of their OCD occurred “right away,” while the remainder reported
onset of symptoms within the first 6 months after delivery.
Type of obsessions and compulsions reported as primary symptoms by the PR and
NP subgroups is described in Table 7. Only obsessions regarding contamination were
significantly greater in the PR subgroup (66.7%) versus the NP subgroup (35.9%)
(X2=6.33, df=1, p=0.01). Interestingly, aggressive obsessions regarding the infant did not
differ statistically.

IVc. Changes in Existing OCD During Pregnancy and the Premenstruum: Group and
Subgroup Comparisons
Women in the Preg group who had onset of OCD prior to becoming pregnant
reported worsening of symptoms with pregnancy in 45 (34.1%) cases, no change in 58
(43.9%), and improvement in 29 (22.0%). These results are reported in terms of
pregnancies (rather than percentage of women) since nine women reported an
exacerbation of OCD symptoms during one pregnancy, yet an improvement or no change
during another. Women in the Preg and NPreg groups experienced worsening of
symptoms prior to menses at approximately the same rate (48.4% of Preg, 51.6% of
NPreg – see Table 3). As shown in Table 5, when women in the PR group were
combined with those who reported any pregnancy-related worsening, there was a
significant association with premenstrual worsening of OCD symptoms (X2=3.93, df=1,
P=.047).
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V.

Conclusion/Discussion

Main Findings:
Pregnancy and childbirth are characterized by enormous physiologic and
psychological demands for the woman. The findings from our study add to the growing
literature suggesting that pregnancy and childbirth can trigger the onset of OCD or the
exacerbation of the ongoing disorder in a substantial number of women. Our discovery
that roughly 30% of women experienced a perinatal related onset of the disorder is
similar to that reported by others (10, 11). The predicted relationship between
pregnancy-related symptoms and PMS related symptoms was confirmed, suggesting that
there is a "hormone related" subtype of OCD in women. Women with pregnancy-related
onset of OCD or perinatal worsening of pre-existing OCD are more likely to experience
premenstrual exacerbation of their OCD symptoms when compared to those women with
previous pregnancies but onset of OCD outside the perinatal period or no perinatal
worsening. This latter finding is similar to what has been observed in affective disorders
such as PMDD and PPD (87). In terms of changes in preexisting OCD, our results about
changes during pregnancy are in agreement with previous studies, which reported both
improvement and worsening of symptoms at this reproductive event.
In terms of specific symptoms present among our subjects, although there was a
significantly greater amount of contamination obsessions reported by the PR group
(which is consistent with prior research), we were surprised to find no significant
difference between the groups in obsessions or compulsions related to typical postpartum
behaviors (i.e., checking, cleaning, ordering/arranging). We hypothesized that women
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with postpartum OCD would be more likely to have these types of symptoms as
abnormal manifestations of normal maternal behavior. In addition, there was no
significant difference found between the PR and NP groups in terms of having aggressive
obsessions (including related to harming the infant), and there was a lower than expected
proportion of women in the PR group (25%) reporting worries about aggression or harm
to the infant. These findings are likely due to the stigma surrounding having these
thoughts, and the resulting fear of admitting their presence in an interview format.
Although, as described above, a majority of women in the PR subgroup reported
acute onset of OCD symptoms, our hypothesis that this would differ significantly from
that reported by women with onset unrelated to pregnancy was not supported.
The comorbidity rate of about 65% of mood disorders (primarily major
depression) in both groups of women is consistent with the results of previous research.
However, our hypothesis that this percentage would be higher in the PR group versus the
NP group was not supported. Moreover, in this sample and with the measures available,
we did not find a significant difference between the groups in terms of family history of
OCD or postpartum OCD/affective disorders.

Study Limitations:
Based on the retrospective studies that have been done, as many as 11% to 47% of
women have their first onset of OCD in the peripartum period (13, 14, 92). Our results
also suggest that both pregnancy and the postpartum may be periods of risk for the
initiation of OCD, with the two periods conferring relatively equal risk. However, the
results of prior research, including our study, are limited by their reliance on retrospective
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recall. As discussed, there are no prospective studies analyzing the course of OCD
during different reproductive events. Future prospective studies are necessary to further
clarify the prevalence of OCD during pregnancy and the postpartum period, as well as to
identify subgroups of women who may be particularly vulnerable to the development of
this disorder. Another limitation of our study is the relatively small sample size, which
reduces statistical power and makes it difficult to obtain definitive conclusions. If the
sample size was increased, some of our negative results may have achieved significance.
In addition, this study did not investigate changes in symptom severity specifically in the
postpartum period; this is a definite weakness, as some women may have not been able to
distinguish between pregnancy and the postpartum period when asked to recall changes
in their symptoms at that time. Again, prospective assessments could address this
weakness in the present research.

Future Directions:
In reviewing the literature, several suggestions can be made for future studies.
Based on the results of Maina’s study, which showed that postpartum OCD was much
more frequent in the context of certain pregnancy complications or characteristics (14),
future studies should include an assessment of obstetric complications in women with
peripartum OCD symptoms. In addition, more studies need to consider the role of
breastfeeding, as this extends and contributes to the period of hormonal fluctuations and
often delays the return of the ovarian cycle. Regarding obsessions of harming the infant,
future studies should assess these thoughts in more detail, including their frequency, the
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level of distress induced, and the mother’s assessment of the likelihood that she would
carry out such thoughts.
Likewise, in future studies, greater emphasis should be placed on determining
comorbid psychiatric diagnoses, as there is a high rate of comorbidity between OCD and
major depression, even when related to pregnancy. In terms of treatment, the efficacy of
high-potency dopaminergic antagonists in the treatment of certain OCD patients, as well
as evidence linking dopamine excess to compulsive behaviors, argue for further
exploration of the dopaminergic system.

Conclusions:
Even if no physical harm is done to the infant as a result of a mother’s obsessional
thoughts, these thoughts may negatively affect the infant’s development in a variety of
ways. For example, mothers who fear harming their infants may avoid them as a result,
preventing the development of a secure mother-child relationship and affecting proper
infant care. In addition, these obsessional thoughts likely affect a mother’s confidence in
her abilities, and may further hinder the development of a close relationship with her
child (76). Increasing data shows that a poor early interaction between the parent and the
infant may have detrimental long-term effects on the child, including increased
vulnerability to stress and an increased risk for developing psychiatric disorders later in
life (88, 89). Animal studies have also highlighted the importance of early mothering in
determining the future maternal behavior of the adult offspring (90, 91).
OCD in the peripartum period is probably an underdiagnosed entity. It is thus
crucial for healthcare providers to inquire about these problems and be aware of their
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potential consequences, so that early intervention may take place. Women should be
reassured that the occurrence of intrusive ego-dystonic thoughts is common, so that they
may receive appropriate care without having to suffer in silence. Also, the extent to
which peripartum OCD predicts increased likelihood of recurrence of the disorder during
or after future pregnancies needs to be investigated, and if possible, prophylactic efforts
should be made. Given current theories on the etiology of puerperal mental illness, it
may be helpful for physicians to inquire about the severity of PMS symptoms, as well as
personal and family psychiatric history, when attempting to perform risk assessment for a
patient.
That approximately half (46-56%) of all of the women in this study, regardless of
pregnancy history, reported a worsening of OCD symptoms during the premenstruum
suggests that clinicians should consider the premenstruum as a trigger for symptom
exacerbation and make decisions regarding treatment accordingly. Women with OCD
who feel that their symptoms worsen in the premenstruum should keep a daily diary of
symptom severity similar to that which is done by women undergoing evaluation for
premenstrual dysphoric disorder. As a goal for future research, it would be interesting to
prospectively assess the premenstruum and the puerperium in the same group of patients
to determine if worsening of OCD during the premenstruum could act as a predictor of
worsening or onset related to pregnancy.
Despite the limitations acknowledged above, our findings provide additional
evidence that pregnancy and childbirth are frequently associated with the onset of OCD
or worsening of symptoms in those with pre-existing disorder. In addition, the results of
our research point to the relatively significant role of gonadal hormones in this
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phenomenon; there appears to be continuity between OCD onset and/or exacerbation
across the reproductive life cycle, at least with menstruation and pregnancy. Although
the premenstruum, pregnancy, and postpartum periods all have differing hormonal shifts,
they can all be characterized as hormonally unstable periods relative to other times in a
woman’s life cycle. Appreciating and understanding the role these hormones play in
influencing the course of OCD may help to elucidate potential neurobiological
mechanisms of this psychopathology, and will hopefully lead to the development of new
concepts in treatment. However, concurrent with these hormonal fluctuations are
dramatic and potentially stressful changes in the mother’s psychosocial and interpersonal
situation. Future studies will need to be designed in such a manner to begin to tease
apart the relative contributions incorporated in the biopsychosocial model of the
pathogenesis of OCD in the perinatal context.
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Table 1. Demographic and Clinical Information - Preg vs.
NPreg
Never
Pregnant
(N=48)

Pregnant
(N=78)

Age on Admission

N

Mean±SD or
(%)

N

Mean±SD or
(%)

77

40.8±10.8

48

32.6±13.0

69
5
1

(92)
(6.7)
(1.3)

47
1
0

(98)
(2)
(0)

Statistics
t=3.82, df=123,
P=.0002

Race
Caucasian
Hispanic
Other
Marital
Single
Married
Divorced

X2=2.01, df=2, P=.37

X2=40.5, df=2,
P=.0001

8
54
15

(10.4)
(70.1)
(19.5)

31
14
3

(64.6)
(29.2)
(6.3)

31

(40.8)

10

(21.3)

15

(19.7)

17

(36.2)

30

(39.5)

20

(42.3)

37
58
76

27.0±5.9
54.8±12.3
26.0±9.0

26
40
46

25.1±5.9
55.4±10.9
23.8±10.6

t=1.27, df=61, P=.21
t=0.24, df=96, P=.81
t=1.22, df=120, P=.23

78

1.0±1.7

47

0.9±1.5

t=0.39, df=123, P=.70

Any

48

(61.5)

34

(70.8)

X2=1.13, df=1, P=.29

Substance abuse

0

(0)

1

(2.1)

X2=1.64, df=1, P=.20

Affective disorder

41

(52.6)

25

(52.1)

X2=0.003, df=1,

Education
H.S. or less
Technical
school/partial
college
College or
professional school
Baseline Y-BOCS
Baseline GAF
Age onset of OCD
Number prior
psych
hospitalizations

X2=6.4, df=2, P=.04

Co-morbid
diagnoses

35
P=.96
Other anxiety
disorder

10

(12.8)

7

(14.6)

X2=0.08, df=1, P=.78

13

(16.7)

11

(22.9)

X2=0.75, df=1, P=.39

Any

69

(90.8)

39

(81.3)

X2=2.38, df=1, P=.12

Substance abuse

13

(16.7)

9

(18.8)

X2=0.09, df=1, P=.76

Affective disorder

18

(23.1)

12

(25.0)

X2=0.06, df=1, P=.81

9

(11.5)

3

(6.3)

X2=0.96, df=1, P=.33

3

(3.9)

0

(0)

X2=1.89, df=1, P=.17

8

(10.3)

2

(4.2)

X2=1.51, df=1, P=.22

Other
Family history

OCD
Other anxiety
disorder
Other
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Table 2. Demographic and Clinical Information - PR vs. NP

Age on Admission

N

Pregnancy
Related
Onset (N=24)
Mean±SD or
(%)

N

Onset
Unrelated to
Pregnancy
(N=53)
Mean±SD or
(%)

24

39.3±8.2

53

41.5±11.8

Race
Caucasian
Hispanic
Other

21
1
1

(91.3)
(4.4)
(4.3)

48
4
0

(92.3)
(7.7)
(0)

Marital
Single
Married
Divorced

4
16
4

(16.7)
(66.7)
(16.7)

4
38
11

(7.6)
(71.7)
(20.7)

Education
H.S. or less
Technical
school/partial college
College or
professional school

Statistics
t=0.81, df=75,
P=.42

Χ2=2.53, df=2,
P=.28

Χ2=1.52, df=2,
P=.47

Χ2=1.01, df=2,
P=.60

8

(33.3)

23

(44.2)

6

(25.0)

9

(17.3)

10

(41.7)

20

(38.5)

Baseline Y-BOCS

13

29.5±7.0

24

25.74.9

Baseline GAF

19

51.6±7.1

39

56.314.0

Age onset of OCD

24

27.0±7.1

52

25.59.8

t=1.93, df=35,
P=.06
t=1.36, df=56,
P=.18
t=0.70, df=74,
P=.49

Number prior psych
hospitalizations

24

1.2±2.0

54

0.91.6

t=0.67, df=76,
P=.51

Co-morbid diagnoses
Any
Substance abuse

13
0

(54.2)
(0)

35
0

(64.8)
(0)

X2=0.80, df=1,
P=.37
N/A

Affective disorder

12

(50)

29

(53.7)

X2=0.09, df=1,

37
P=.76
2

Other anxiety disorder

4

(16.7)

6

(11.1)

Other

1

(4.2)

12

(22.2)

Family history
Any

20

(87.0)

49

(92.5)

Substance abuse

1

(4.2)

12

(22.2)

Affective disorder

5

(20.8)

13

(24.1)

OCD

2

(8.3)

7

(13.0)

Other anxiety disorder

1

(4.2)

2

(3.7)

Other

2

(8.3)

6

(11.1)

X =0.46, df=1,
P=.50
2
X =3.9, df=1,
P=.05

X2=0.58, df=1,
P=.45
2
X =3.90, df=1,
P=.05
X2=0.10, df=1,
P=.75
X2=0.35, df=1,
P=.55
2
X =0.10, df=1,
P=.92
X2=0.14, df=1,
P=.71
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Table 3. OCD and Reproductive Events - Preg vs. NPreg

Pregnant
(N=78)

Never
Pregnant
(N=48)
Mean±SD or
(%)

Statistics

N

Mean±SD or
(%)

Number of
pregnancies

68

2.5±1.5

N/A

N/A

Number of
abortions/miscarriage
s

66

0.5±0.8

N/A

N/A

N

Lifetime course of
OCD
Episodic
Chronic

3
69

(4.2)
(95.8)

0
43

(0)
(100)

X2=1.84, df=1,
P=.18

Initial onset of major
syndrome
Acute
Gradual
Symptom changes
prior to menses
No change
Worse
Uncertain

33
36

(47.8)
(52.2)

11
24

(31.4)
(68.6)

27

(43.5)

14

(45.2)

16
1

(51.6)
(3.2)

X2=2.56, df=1,
P=.11

X2=0.81, df=2,
P=.67

30
5

(48.4)
(8.1)

Onset - pregnancy
No
Yes

66
12

(84.6)
(15.4)

N/A

N/A

Onset - post loss
No
Yes

18
1

(94.7)
(5.3)

N/A

N/A

39
Onset - postpartum
No
Yes

66
12

(84.6)
(15.4)

N/A

N/A

Table 4. OCD and Reproductive Events - PR vs.
NP
Pregnancyrelated Onset
(N=24)

Onset
unrelated to
Pregnancy
(N=54)

Statistics

N

Mean±SD or
(%)

N

Mean±SD or
(%)

Number of
pregnancies

2
4

2.6±1.5

4
4

2.45±1.5

t=-0.46, df=66,
P=.65

Number of
abortions/miscarriage
s

2
4

0.6±0.9

4
2

0.6±0.79

N/A

Lifetime course of
OCD
Episodic
Chronic

1
2
0

(4.8)
(95.2)

2
4
9

(3.9)
(96.1)

Initial onset of major
syndrome
Acute

1
3

(61.9)

Gradual

8

(38.1)

2
0
2
8

(41.7)

No change

6

(37.5)

Worse
Uncertain

9
1

(56.3)
(6.2)

Onset - pregnancy

Χ2=2.40, df=1,
P=.12

(58.3)

Symptom changes
prior to menses
2
1
2
1
4

Χ2=0.03, df=1,
P=.87

(45.7)
(45.7)
(8.7)

Χ2=0.54, df=2,
P=.76

40
1
2
1
2

No
Yes
Onset - post loss
No
Yes

7
1

(50.0)

N/A

N/A

(87.5)
(12.5)

N/A

N/A

(50.0)

N/A

N/A

(50.0)

Onset - postpartum
1
2
1
2

No
Yes

(50.0)

Table 5. OCD and Reproductive Events - Combined Analysis
Onset Related
OR worsening
Sx during
Pregnancy
N

Mean±SD or (%)

N

Onset
Unrelated to
Pregnancy
Mean±SD or
(%)

Symptom
changes
prior to
menses
No
change

10 (34.5)

17 (60.7)

Worse

19 (65.5)

11 (39.3)

Statistics

X2=3.93, df=1,
P=.047
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Table 6. Major OCD Symptoms - Preg vs. NPreg

Pregnant
(N=77)

Never
Pregnant
(N=48)

N (%)

N (%)

Aggressive

22 (28.6)

18 (37.5)

Χ2=1.08, df=1, P=.30

Contamination

35 (45.5)

23 (47.9)

Χ2=0.07, df=1, P=.79

Sexual

4 (5.2)

7 (14.6)

Χ2=3.25, df=1, P=.07

Hoarding/saving

5 (6.5)

6 (12.5)

Χ2=1.33, df=1, P=.25

Religious/scrupulosity

3 (3.9)

8 (16.7)

Χ2=6.01, df=1, P=.01

Symmetry/exactness

17 (22.1)

13 (27.1)

Χ2=0.41, df=1, P=.52

Somatic/illness

5 (6.5)

4 (8.3)

Χ2=0.15, df=1, P=.70

Misc. obsessions

23 (30)

15 (31)

Χ2=0.03, df=1, P=.87

Cleaning/washing

45 (58.4)

23 (47.9)

Χ2=1.32, df=1, P=.25

Checking

38 (49.4)

27 (56.3)

Χ2=0.56, df=1, P=.45

Repeating

24 (31.2)

18 (37.5)

Χ2=0.53, df=1, P=.47

Counting

12 (15.6)

11 (22.9)

Χ2=1.06, df=1, P=.30

Ordering/arranging

17 (22.1)

3 (6.3)

Χ2=5.51, df=1, P=.02

5 (6.5)

8 (16.7)

Χ2=3.28, df=1, P=.07

11 (14.3)

16 (33.3)

Χ2=6.33, df=1, P=.01

16 (20.8)

n/a

3.7±1.4
(n=77)

4.2±2.0
(n=48)

Statistics

Major OCD Symptoms

Collecting
Misc. compulsions
Worry - aggression/harm to
babies
Total number of major
symptoms

t=1.8, df=123, P=.07

Note: One woman in the Pregnant Group had missing data thus the sample size for this table
was n=77
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Table 7. Major OCD Symptoms - PR vs. NP
Pregnancyrelated
Onset
(N=24)

Onset
unrelated to
Pregnancy
(N=53)

N (%)

N (%)

Major OCD Symptoms
Aggressive

5 (20.8)

17 (32.1)

Contamination

16 (66.7)

19 (35.9)

1 (4.2)

3 (5.7)

0 (0)

5 (9.4)

Religious/scrupulosity

1 (4.2)

2 (3.8)

Symmetry/exactness

6 (25.0)

11 (20.8)

Somatic/illness

2 (8.3)

3 (5.7)

Misc. obsessions

6 (25.0)

17 (32.1)

Cleaning/washing

17 (10.8)

28 (52.8)

Checking

12 (50.0)

26 (49.1)

Repeating

8 (33.3)

16 (30.2)

Counting

1 (4.2)

11 (20.8)

Ordering/arranging

6 (25.0)

11 (20.8)

0 (0)

5 (9.4)

2 (8.3)

9 (17.0)

6 (25.0)

10 (18.9)

Sexual
Hoarding/saving

Collecting
Misc. compulsions
Worry - aggression/harm to
babies

Statistics

X2=1.02, df=1,
P=.31
2
X =6.33, df=1,
P=.01
X2=0.07, df=1,
P=.78
X2=2.42, df=1,
P=.12
X2=0.01, df=1,
P=.93
X2=0.17, df=1,
P=.68
X2=0.19, df=1,
P=.66
X2=0.39, df=1,
P=.53
X2=2.20, df=1,
P=.14
X2=0.01, df=1,
P=.94
X2=0.08, df=1,
P=.78
X2=3.46, df=1,
P=.06
X2=0.17, df=1,
P=.68
X2=2.42, df=1,
P=.12
X2=1.01, df=1,
P=.32
X2=0.38, df=1,
P=.54

Total number of major
t=0.19, df=75,
symptoms
3.7±1.3 (n=24) 3.6±1.5 (n=53)
P=.85
Note: One woman in the Onset Unrelated to Pregnancy Group did not have this
information thus sample size for this table is N=53

43

References
1.
Turnbull JM. Mental illness in the puerperium. Canadian Psychiatric Association
Journal 14(5):525-6, 1969 Oct.
2.
First MB, ed. Diagnostic and Statistical Manual - Text Revision (DSM-IV-TR™,
2000). IV-TR ed. Washington, DC: American Psychiatric Association; 2000.
3.
Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of
obsessive-compulsive disorder in five US communities. Archives of General Psychiatry
45(12):1094-9, 1988 Dec.
4.
Rasmussen SA, Eisen JL. Epidemiology of obsessive compulsive disorder.
[Review] [22 refs]. Journal of Clinical Psychiatry 51 Suppl:10-3; discussion 14, 1990
Feb.
5.
Bebbington PE. Epidemiology of obsessive-compulsive disorder. Br J
Psychiatry;Suppl (35):2-6, 1998.
6.
Brandes M, Soares CN, Cohen LS. Postpartum onset obsessive-compulsive
disorder: diagnosis and management. [Review] [152 refs]. Archives of Women's Mental
Health 7(2):99-110, 2004 Apr.
7.
Pollitt J. Natural history of obsessional states. British Medical Journal
1957;9:133-40.
8.
Ingram IM. Obsessional illness in mental hospital patients. Journal of Mental
Science 1961;107:382-402.
9.
Lo WH. A follow-up study of obsessional neurotics in Hong Kong Chinese. Br J
Psychiatry 1967;113(501):823-32.
10.
Buttolph ML, & Holland, A.D. Obsessive-compulsive disorders in pregnancy and
childbirth. In: M. Jenike LB, & W. Minichiello, ed. Obsessive-compulsive disorders:
theory and management. Chicago: Year Book Medical; 1990:89-97.
11.
Neziroglu F, Anemone R, Yaryura-Tobias JA. Onset of obsessive-compulsive
disorder in pregnancy.[see comment]. Am J Psychiatry 1992;149(7):947-50.
12.
Sichel DA, Cohen LS, Rosenbaum JF, Driscoll J. Postpartum onset of obsessivecompulsive disorder. Psychosomatics 34(3):277-9, 1993 May-Jun.
13.
Williams KE, Koran LM. Obsessive-compulsive disorder in pregnancy, the
puerperium, and the premenstruum. Journal of Clinical Psychiatry 58(7):330-4; quiz 3356, 1997 Jul.
14.
Maina G, Albert U, Bogetto F, Vaschetto P, Ravizza L. Recent life events and
obsessive-compulsive disorder (OCD): the role of pregnancy/delivery. Psychiatry
Research 89(1):49-58, 1999 Dec 13.
15.
Labad J, Menchon JM, Alonso P, Segalas C, Jimenez S, Vallejo J. Female
reproductive cycle and obsessive-compulsive disorder. Journal of Clinical Psychiatry
66(4):428-35; quiz 546, 2005 Apr.
16.
Brandt KR, Mackenzie TB. Obsessive-compulsive disorder exacerbated during
pregnancy: a case report. International Journal of Psychiatry in Medicine 17(4):361-6,
1987.
17.
Geller PA, Klier CM, Neugebauer R. Anxiety disorders following miscarriage.
Journal of Clinical Psychiatry 62(6):432-8, 2001 Jun.

44
18.
Altshuler LL, Hendrick V, Cohen LS. Course of mood and anxiety disorders
during pregnancy and the postpartum period. [Review] [68 refs]. Journal of Clinical
Psychiatry 59 Suppl 2:29-33, 1998.
19.
Sichel DA, Cohen LS, Dimmock JA, Rosenbaum JF. Postpartum obsessive
compulsive disorder: a case series. Journal of Clinical Psychiatry 54(4):156-9, 1993 Apr.
20.
Iancu I, Lepkifker E, Dannon P, Kotler M. Obsessive-compulsive disorder limited
to pregnancy. Psychotherapy & Psychosomatics 64(2):109-12, 1995.
21.
Arnold L. A case series of women with postpartum-onset obsessive-compulsive
disorder. J Clin Psychiatry 1999;1:103-8.
22.
Rauch SL, Jenike MA. Neurobiological models of obsessive-compulsive disorder.
[Review] [106 refs]. Psychosomatics 34(1):20-32, 1993 Jan-Feb.
23.
Jenike MA, Hyman S, Baer L, et al. A controlled trial of fluvoxamine in
obsessive-compulsive disorder: implications for a serotonergic theory.[see comment].
American Journal of Psychiatry 147(9):1209-15, 1990 Sep.
24.
Jenike MA, Rauch SL, Cummings JL, Savage CR, Goodman WK. Recent
developments in neurobiology of obsessive-compulsive disorder. Journal of Clinical
Psychiatry 57(10):492-503, 1996 Oct.
25.
McDougle CJ, Goodman WK, Price LH, et al. Neuroleptic addition in
fluvoxamine-refractory obsessive-compulsive disorder. American Journal of Psychiatry
147(5):652-4, 1990 May.
26.
Pitman RK. Animal models of compulsive behavior. [Review] [66 refs].
Biological Psychiatry 26(2):189-98, 1989 Jun.
27.
Insel TR. Toward a neuroanatomy of obsessive-compulsive disorder.[see
comment]. [Review] [57 refs]. Archives of General Psychiatry 49(9):739-44, 1992 Sep.
28.
Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional
neuroimaging in obsessive-compulsive disorder. Psychiatry Research 132(1):69-79, 2004
Nov 15.
29.
Speroff L, Fritz M, eds. Clinical Gynecologic Endocrinology & Infertility. 7th
Edition ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
30.
Glaser J, Russell VA, de Villiers AS, Searson JA, Taljaard JJ. Rat brain
monoamine and Serotonin S2 receptor changes during pregnancy. Neurochemical
Research 15(10):949-56, 1990 Oct.
31.
Pecins-Thompson M, Brown NA, Kohama SG, Bethea CL. Ovarian Steroid
Regulation of Tryptophan Hydroxylase mRNA Expression in Rhesus Macaques. J
Neurosci 1996;16(21):7021-9.
32.
Sumner BEH, Fink G. The density of 5-hydoxytryptamine2A receptors in
forebrain is increased at pro-oestrus in intact female rats. Neuroscience Letters
1997;234(1):7-10.
33.
Ehrenkranz JR. Effects of sex steroids on serotonin uptake in blood platelets. Acta
Endocrinologica 83(2):420-8, 1976 Oct.
34.
Biegon A, McEwen BS. Modulation by estradiol of serotonin receptors in brain.
Journal of Neuroscience 2(2):199-205, 1982 Feb.
35.
Moskovitz RA, Lingao A. Binge eating associated with oral contraceptives.
American Journal of Psychiatry 136(5):721-2, 1979 May.
36.
Calanchini C. [Development of a compulsive syndrome by ovulation inhibitors].
[German]. Schweizer Archiv fur Neurologie und Psychiatrie 137(4):25-31, 1986.

45
37.
Lochner C, Hemmings SM, Kinnear CJ, et al. Corrigendum to "gender in
obsessive-compulsive disorder: clinical and genetic findings" [Eur.
Neuropsychopharmacol. 14 (2004) 105-113].[republished from Eur
Neuropsychopharmacol. 2004 Mar;14(2):105-13; PMID: 15013025]. European
Neuropsychopharmacology 14(5):437-45, 2004 Oct.
38.
Dalton K. Prospective study into puerperal depression. British Journal of
Psychiatry 118(547):689-92, 1971 Jun.
39.
Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause
and beyond. [Review] [183 refs]. Journal of Affective Disorders 74(1):67-83, 2003 Mar.
40.
Leckman JF, Goodman WK, North WG, et al. The role of central oxytocin in
obsessive compulsive disorder and related normal behavior. [Review] [230 refs].
Psychoneuroendocrinology 19(8):723-49, 1994.
41.
Denys D, Zohar J, Westenberg HG. The role of dopamine in obsessivecompulsive disorder: preclinical and clinical evidence. Journal of Clinical Psychiatry 65
Suppl 14:11-7, 2004.
42.
Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S. Glutamatergic
dysfunction in OCD. Neuropsychopharmacology 30(9):1735-40, 2005 Sep.
43.
Silverman AJ, Zimmerman EA. Magnocellular neurosecretory system. Annual
Review of Neuroscience 6:357-80, 1983.
44.
Insel TR. Oxytocin--a neuropeptide for affiliation: evidence from behavioral,
receptor autoradiographic, and comparative studies. [Review] [144 refs].
Psychoneuroendocrinology 17(1):3-35, 1992.
45.
Pedersen CA, Prange AJ, Jr. Induction of maternal behavior in virgin rats after
intracerebroventricular administration of oxytocin. Proceedings of the National Academy
of Sciences of the United States of America 76(12):6661-5, 1979 Dec.
46.
McCarthy MM. Oxytocin inhibits infanticide in female house mice (Mus
domesticus). Hormones & Behavior 24(3):365-75, 1990 Sep.
47.
Kaltwasser MT, Crawley JN. Oxytocin and cholecystokinin induce grooming
behavior in the ventral tegmentum of the rat. Brain Research 426(1):1-7, 1987 Nov 17.
48.
Miller FD, Ozimek G, Milner RJ, Bloom FE. Regulation of neuronal oxytocin
mRNA by ovarian steroids in the mature and developing hypothalamus. Proceedings of
the National Academy of Sciences of the United States of America 86(7):2468-72, 1989
Apr.
49.
Sofroniew MV WA. Central nervous system distribution of vasopressin, oxytocin,
and neurophysin. In: Martinez JL JR, Mesin RB, Rigter H, McGraugh JL, ed.
Endogenous Peptides and Learning and Memory Processes. New York: Academic Press;
1981:327-69.
50.
Leckman JF, Goodman WK, North WG, et al. Elevated cerebrospinal fluid levels
of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and
healthy controls. Archives of General Psychiatry 51(10):782-92, 1994 Oct.
51.
Greer ER, Caldwell JD, Johnson MF, Prange AJ, Jr., Pedersen CA. Variations in
concentration of oxytocin and vasopressin in the paraventricular nucleus of the
hypothalamus during the estrous cycle in rats. Life Sciences 38(25):2311-8, 1986 Jun 23.
52.
Yamaguchi K, Akaishi T, Negoro H. Effect of estrogen treatment on plasma
oxytocin and vasopressin in ovariectomized rats. Endocrinologia Japonica 26(2):197-205,
1979 Apr.

46
53.
De Kloet ER, Rotteveel F, Voorhuis TA, Terlou M. Topography of binding sites
for neurohypophyseal hormones in rat brain. European Journal of Pharmacology
110(1):113-9, 1985 Mar 26.
54.
Rhodes CH, Morrell JI, Pfaff DW. Estrogen-concentrating neurophysincontaining hypothalamic magnocellular neurons in the vasopressin-deficient
(Brattleboro) rat: a study combining steroid autoradiography and immunocytochemistry.
Journal of Neuroscience 2(12):1718-24, 1982 Dec.
55.
Insel TR. Postpartum increases in brain oxytocin binding. Neuroendocrinology
44(4):515-8, 1986.
56.
Kendrick KM, Keverne EB, Hinton MR, Goode JA. Cerebrospinal fluid and
plasma concentrations of oxytocin and vasopressin during parturition and vaginocervical
stimulation in the sheep. Brain Research Bulletin 26(5):803-7, 1991 May.
57.
Altemus M, Jacobson KR, Debellis M, et al. Normal CSF oxytocin and NPY
levels in OCD. Biological Psychiatry 45(7):931-3, 1999 Apr 1.
58.
Swedo SE, Leonard HL, Kruesi MJ, et al. Cerebrospinal fluid neurochemistry in
children and adolescents with obsessive-compulsive disorder. Archives of General
Psychiatry 49(1):29-36, 1992 Jan.
59.
Ansseau M, Legros JJ, Mormont C, et al. Intranasal oxytocin in obsessivecompulsive disorder. Psychoneuroendocrinology 12(3):231-6, 1987.
60.
den Boer JA, Westenberg HG. Oxytocin in obsessive compulsive disorder.
Peptides 13(6):1083-5, 1992 Nov-Dec.
61.
Epperson CN, McDougle CJ, Price LH. Intranasal oxytocin in obsessivecompulsive disorder. Biological Psychiatry 40(6):547-9, 1996 Sep 15.
62.
Abramowitz J, Moore K, Carmin C, Wiegartz PS, Purdon C. Acute onset of
obsessive-compulsive disorder in males following childbirth. Psychosomatics 42(5):42931, 2001 Sep-Oct.
63.
Nestadt G, Samuels J, Riddle M, et al. A family study of obsessive-compulsive
disorder. Archives of General Psychiatry 57(4):358-63, 2000 Apr.
64.
Pauls DL, Alsobrook JP, 2nd, Goodman W, Rasmussen S, Leckman JF. A family
study of obsessive-compulsive disorder. American Journal of Psychiatry 152(1):76-84,
1995 Jan.
65.
Sciuto G, Pasquale L, Bellodi L. Obsessive compulsive disorder and mood
disorders: a family study. American Journal of Medical Genetics 60(6):475-9, 1995 Dec
18.
66.
Camarena B, Rinetti G, Cruz C, Gomez A, de La Fuente JR, Nicolini H.
Additional evidence that genetic variation of MAO-A gene supports a gender subtype in
obsessive-compulsive disorder. American Journal of Medical Genetics 105(3):279-82,
2001 Apr 8.
67.
Cavallini MC, Pasquale L, Bellodi L, Smeraldi E. Complex segregation analysis
for obsessive compulsive disorder and related disorders. American Journal of Medical
Genetics 88(1):38-43, 1999 Feb 5.
68.
Noshirvani HF, Kasvikis Y, Marks IM, Tsakiris F, Monteiro WO. Genderdivergent aetiological factors in obsessive-compulsive disorder. British Journal of
Psychiatry 158:260-3, 1991 Feb.

47
69.
Rasmussen SA, Tsuang MT. Clinical characteristics and family history in DSMIII obsessive-compulsive disorder. American Journal of Psychiatry 143(3):317-22, 1986
Mar.
70.
Paykel ES, Emms EM, Fletcher J, Rassaby ES. Life events and social support in
puerperal depression. British Journal of Psychiatry 136:339-46, 1980 Apr.
71.
Leckman JF, Herman AE. Maternal behavior and developmental
psychopathology. Biological Psychiatry 51(1):27-43, 2002 Jan 1.
72.
Leckman JF, Feldman R, Swain JE, Eicher V, Thompson N, Mayes LC. Primary
parental preoccupation: circuits, genes, and the crucial role of the environment. [Review]
[120 refs]. Journal of Neural Transmission 111(7):753-71, 2004 Jul.
73.
Winnicott D. Primary maternal preoccupation. In: Collected Papers: Through
Paediatrics to Psycho-Analysis. New York: Basic Books; 1956.
74.
Leckman JF, Mayes LC, Feldman R, Evans DW, King RA, Cohen DJ. Early
parental preoccupations and behaviors and their possible relationship to the symptoms of
obsessive-compulsive disorder. Acta Psychiatrica Scandinavica, Supplementum 396:126, 1999.
75.
Wisner KL, Peindl KS, Gigliotti T, Hanusa BH. Obsessions and compulsions in
women with postpartum depression. Journal of Clinical Psychiatry 60(3):176-80, 1999
Mar.
76.
Jennings KD, Ross S, Popper S, Elmore M. Thoughts of harming infants in
depressed and nondepressed mothers. Journal of Affective Disorders 54(1-2):21-8, 1999
Jul.
77.
Salkovskis PM. Understanding and treating obsessive-compulsive disorder.
[Review] [55 refs]. Behaviour Research & Therapy 37 Suppl 1:S29-52, 1999 Jul.
78.
Rachman S, de Silva P. Abnormal and normal obsessions. Behaviour Research &
Therapy 16(4):233-48, 1978.
79.
Stern RS, Cobb JP. Phenomenology of obsessive-compulsive neurosis. Br J
Psychiatry 1978;132:233-9.
80.
Bellodi L, Sciuto G, Diaferia G, Ronchi P, Smeraldi E. Psychiatric disorders in
the families of patients with obsessive-compulsive disorder. Psychiatry Research
42(2):111-20, 1992 May.
81.
Barlow D. Obsessive compulsive disorder. In: DH B, ed. Anxiety and Its
Disorders. New York: The Guilford Press; 1989:598-635.
82.
Rasmussen SA, Eisen JL. The epidemiology and differential diagnosis of
obsessive compulsive disorder. [Review] [35 refs]. Journal of Clinical Psychiatry 55
Suppl:5-10; discussion 11-4, 1994 Oct.
83.
Button JH, Reivich RS. Obsessions of infanticide. A review of 42 cases. Archives
of General Psychiatry 27(2):235-40, 1972 Aug.
84.
Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of specific
psychiatric disorders in three sites. Archives of General Psychiatry 41(10):949-58, 1984
Oct.
85.
First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for
DSM-IV Axis I Disorders- Patient Edition SCID-I/P. New York: New York State
Psychiatric Institute; 1995.

48
86.
Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive
Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry
46(11):1006-11, 1989 Nov.
87.
Bloch M, Rotenberg N, Koren D, Klein E. Risk factors associated with the
development of postpartum mood disorders. Journal of Affective Disorders 88(1):9-18,
2005 Sep.
88.
Sroufe LA, Carlson EA, Levy AK, Egeland B. Implications of attachment theory
for developmental psychopathology. [Review] [60 refs]. Development &
Psychopathology 11(1):1-13, 1999.
89.
Kendler KS, Kessler RC, Neale MC, Heath AC, Eaves LJ. The prediction of
major depression in women: toward an integrated etiologic model. American Journal of
Psychiatry 150(8):1139-48, 1993 Aug.
90.
Francis D, Diorio J, Liu D, Meaney MJ. Nongenomic transmission across
generations of maternal behavior and stress responses in the rat. Science 286(5442):11558, 1999 Nov 5.
91.
Suomi SJ RC. A history of motherless mothering at the University of Wisconsin
Primate Laboratory. In: Reite M CN, ed. Child abuse: the non-human data. New York:
Alan R Liss; 1983:49-78.
92.
Leckman JF, Mayes LC. Preoccupations and behaviors associated with romantic
and parental love. Perspectives on the origin of obsessive-compulsive disorder. [Review]
[152 refs]. Child & Adolescent Psychiatric Clinics of North America 8(3):635-65, 1999
Jul.

